11:23 AM EDT, 09/05/2025 (MT Newswires) -- (Updates with response from Advent International in the fourth paragraph.)

Goldman Sachs Group ( GS ) is among the banks competing with private credit companies to fund potential buyers of Advent International's Zentiva, Bloomberg reported Friday, citing people familiar with the matter.

Lenders are readying up to 3 billion euros ($3.52 billion) of debt financing to support a potential sale of Zentiva as a deal approaches, the report said.

Among those interested in the generic drugmaker are TPG (TPG) and GTCR, according to the report.

Advent declined to comment when contacted by MT Newswires, while Goldman, TPG and GTCR did not immediately respond to requests for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 732.04, Change: -16.86, Percent Change: -2.25